Abstract
Diastolic heart failure (DHF) has become a high social burden, and its major underlying cardiovascular disease is hypertensive heart disease. However, the pathogenesis of DHF remains to be clarified. This study aimed to assess the effects of cardiac energy efficiency in DHF patients. 11C-Acetate positron emission tomography and echocardiography were conducted in 11 DHF Japanese patients and 10 normal volunteers. The myocardial clearance rate of radiolabeled 11C-acetate was measured to calculate the work metabolic index (WMI), an index of cardiac efficiency. The ratio of peak mitral E wave velocity to peak early diastolic septal myocardial velocity (E/e′) was calculated to assess left ventricular (LV) filling pressure. The LV mass index was greater and the mean age was higher in the DHF patients than in the normal volunteers. There was no difference in WMI between the two groups. However, WMI varied widely among the DHF patients and was inversely correlated with E/e′ (r=−0.699, p=0.017). In contrast, there was no correlation in the normal volunteers. In conclusion, the inefficiency of energy utilization is not a primary cause of diastolic dysfunction or DHF, and cardiac efficiency may not affect diastolic function in normal hearts. However, the energy-wasting state may induce the elevation of LV filling pressure in DHF patients, which was considered to principally result from the progressive diastolic dysfunction.
Similar content being viewed by others
Article PDF
References
Senni M, Tribouilloy CM, Rodeheffer RJ, et al: Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991. Circulation 1998; 98: 2282–2289.
Vasan RS, Larson MG, Benjamin EJ, Evans JC, Reiss CK, Levy D : Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction. J Am Coll Cardiol 1999; 33: 1948–1955.
Tsutsui H, Tsuchihashi M, Takeshita A : Mortality and readmission of hospitalized patients with congestive heart failure and preserved versus depressed systolic function. Am J Cardiol 2001; 88: 530–533.
Cleland JGF, Swedberg K, Follath F, et al: The European Failure survey programme—a survey on the quality of care among patients with heart failure in Europe. Part 1: Patient characteristics and diagnosis. Eur Heart J 2003; 24: 442–463.
Masuyama T, Yamamoto K, Sakata Y, et al: Evolving changes in Doppler mitral flow velocity pattern in rats with hypertensive hypertrophy. J Am Coll Cardiol 2000; 36: 2333–2338.
Zile MR, Baicu CF, Gaasch WH : Diastolic heart failure—abnormalities in active relaxation and passive stiffness of the left ventricle. N Engl J Med 2004; 350: 1953–1959.
Sakata Y, Masuyama T, Yamamoto K, et al: Calcineurin inhibitor attenuates left ventricular hypertrophy leading to prevention of heart failure in hypertensive rats. Circulation 2000; 102: 2269–2275.
Sakata Y, Masuyama T, Yamamoto K, et al: Renin angiotensin system-dependent hypertrophy as a contributor to heart failure in hypertensive rats: different characteristics from renin angiotensin system-independent hypertrophy. J Am Coll Cardiol 2001; 37: 293–299.
Yamamoto K, Masuyama T, Sakata Y, et al: Myocardial stiffness is determined by ventricular fibrosis, but not by compensatory or excessive hypertrophy in hypertensive heart. Cardiovasc Res 2002; 55: 76–82.
Sakata Y, Yamamoto K, Mano T, et al: Angiotensin II type 1 receptor blockade prevents diastolic heart failure through modulation of Ca2+ regulatory proteins and extracellular matrix. J Hypertens 2003; 21: 1737–1745.
Yamamoto K, Takahashi Y, Mano T, et al: N-Methylethanolamine attenuates cardiac fibrosis and improves diastolic function: inhibition of phospholipase D as a possible mechanism. Eur Heart J 2004; 25: 1221–1229.
Borbély A, van der Velden J, Papp Z, et al: Cardiomyocyte stiffness in diastolic heart failure. Circulation 2005; 111: 774–781.
Brown M, Marshall DR, Sobel BE, Bergmann SR : Delineation of myocaridal oxygen utilization with carbon-11-labeled acetate. Circulation 1987; 76: 687–696.
Armbrecht JJ, Buxton DB, Brunken RC, Phelps ME, Schelbert HR : Regional myocardial oxygen consumption determined noninvasively in humans with [1-11C]acetate and dynamic positron tomography. Circulation 1989; 80: 863–872.
Beanlands RSB, Bach DS, Raylman R, et al: Acute effects of dobutamine on myocardial oxygen consumption and cardiac efficiency measured using carbon-11 acetate kinetics in patients with dilated cardiomyopathy. J Am Coll Cardiol 1993; 22: 1389–1398.
Bengel FM, Permanetter B, Ungerer M, Nekolla S, Schwaiger M : Non-invasive estimation of myocardial efficiency using positron emission tomography and carbon-11 acetate-comparison between the normal and failing human heart. Eur J Nucl Med 2000; 27: 319–326.
The J-DHF Program Committee : Rationale and design of a randomized trial to assess the effects of beta-blocker in diastolic heart failure: Japanese Diastolic Heart Failure Study (J-DHF). J Card Fail 2005; 11: 542–547.
Yamamoto K, Masuyama T, Tanouchi J, et al: Intraventricular dispersion of early diastolic filling: a new marker of left ventricular diastolic dysfunction. Am Heart J 1995; 129: 291–299.
Yamamoto K, Nishimura RA, Chaliki HP, Appleton CP, Holmes DR Jr, Redfield MM : Determination of left ventricular filling pressure by Doppler echocardiography in patients with coronary artery disease: critical role of left ventricular systolic function. J Am Coll Cardiol 1997; 30: 1819–1826.
Yamaguchi H, Yoshida J, Yamamoto K, et al: Elevation of plasma brain natriuretic peptide is a hallmark of diastolic heart failure independent of ventricular hypertrophy. J Am Coll Cardiol 2004; 43: 55–60.
Devereux RB, Alonso DR, Lutas EM, et al: Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57: 450–458.
Nagueh SF, Middleton KJ, Kopelen HA, Zoghibi WA, Quinones MA : Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 1997; 30: 1527–1533.
Kasner M, Westermann D, Steendijk P, et al: Utility of Doppler echocardiography and tissue Doppler imaging in the estimation of diastolic function in heart failure with normal ejection fraction: a comparative Doppler-conductance catheterization study. Circulation 2007; 116: 637–647.
Paulus WJ, Tschope C, Sanderson JE, et al: How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 2007; 28: 2539–2550.
Munakata M, Ito N, Nunokawa T, Yoshinaga K : Utility of automated brachial ankle pulse wave velocity measurements in hypertensive patients. Am J Hypertens 2003; 16: 653–657.
Lang RM, Bierig M, Devereux RB, et al: Recommendations for chamber quantification: a report from the American Society of Echocardiography’s guidelines and quantification writing group, developed in conjunction with the European Association of Echocardiography, a branch of teh European Society of Cardiology. J Am Soc Echocardiogr 2005; 18: 1440–1463.
Nagueh SF, Sun H, Kopelen HA, Middleton KJ, Khoury DS : Hemodynamic determinants of the mitral annulus diastolic velocities by tissue Doppler. J Am Coll Cardiol 2001; 37: 278–285.
Kawaguchi M, Hay I, Fetics B, Kass DA : Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction: implications for systolic and diastolic reserve limitations. Circulation 2003; 107: 714–720.
van Heerebeek L, Borbély A, Niessen HWM, et al: Myocardial structure and function differ in systolic and diastolic heart failure. Circulation 2006; 113: 1966–1973.
Kitzman DW, Higgingotham MB, Cobb FR, Sheikh KH, Sullivan MJ : Exercise intolerance in patients with heart failure and preserved left ventricular systolic function: failure of the Frank-Starling mechanism. J Am Coll Cardiol 1991; 17: 1065–1072.
Muller-Brunotte R, Kahan T, Malmqvist K, Ring M, Edner M : Tissue velocity echocardiography shows early improvement in diastolic function with irbesartan and atenolol therapy in patients with hypertensive left ventricular hypertrophy. Results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA). Am J Hypertens 2006; 19: 927–936.
Janardhanan R, Daley WL, Naqvi TZ, et al: Rationale and design: the VALsartan In Diastolic Dysfunction (VALIDD) Trial: evolving the management of diastolic dysfunction in hypertension. Am Heart J 2006; 152: 246–252.
Schaefer A, Meyer GP, Fuchs M, et al: Impact of intracoronary bone marrow cell transfer on diastolic function in patients after acute myocardial infarction: results from the BOOST trial. Eur Heart J 2006; 27: 929–935.
Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM : Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006; 355: 251–259.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hasegawa, S., Yamamoto, K., Sakata, Y. et al. Effects of Cardiac Energy Efficiency in Diastolic Heart Failure: Assessment with Positron Emission Tomography with 11C-Acetate. Hypertens Res 31, 1157–1162 (2008). https://doi.org/10.1291/hypres.31.1157
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1291/hypres.31.1157
Keywords
This article is cited by
-
Functional and Metabolic Imaging in Heart Failure with Preserved Ejection Fraction: Promises, Challenges, and Clinical Utility
Cardiovascular Drugs and Therapy (2023)
-
Exercise mediated protection of diabetic heart through modulation of microRNA mediated molecular pathways
Cardiovascular Diabetology (2017)
-
Endurance training or beta-blockade can partially block the energy metabolism remodeling taking place in experimental chronic left ventricle volume overload
BMC Cardiovascular Disorders (2014)